Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01886937 · ClinicalTrials.gov registry record · Phase 4

Studying the Effects of Phentermine on Eating Behavior

A Phase 4 study, sponsored by New York State Psychiatric Institute.

Completed
Registry status
Phase 4
Development phase
13
Enrollment target

NCT01886937 is a Phase 4 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01886937, a Phase 4 study, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
Phase 4
Development phase
13 participants
Enrollment target

Study Summary

The goal of this study is to determine whether one week of phentermine compared to placebo administration results in changes in food intake during a laboratory meal.

Interventions

  • DRUG placebo
  • DRUG Phentermine

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2012-07
Est. Completion 2014-06
Phase Phase 4

What the Registry Record Tells You About NCT01886937

The ClinicalTrials.gov registry entry for NCT01886937 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT01886937 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01886937 about?

NCT01886937 is a clinical study titled "Studying the Effects of Phentermine on Eating Behavior". The goal of this study is to determine whether one week of phentermine compared to placebo administration results in changes in food intake during a laboratory meal.

What is the current status of trial NCT01886937?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2012-07. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01886937?

The interventions under investigation include: placebo (DRUG), Phentermine (DRUG).

Who is sponsoring clinical trial NCT01886937?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.